Introduction. The primary aim of this study was to compare the objective and subjective outcomes and short-term complication rates of an adjustable singleincision mini-sling (SIMS) vs. standard mid-urethral slings (SMUS). The secondary aim was to report pain perception and complications at the oneyear follow up. Material and methods. The study was designed as a multicenter prospective randomized trial where women were included from eight centers in Denmark, Norway and Sweden. The trial was registered at ClinicalTrials.gov: NCT01754558. A total of 305 women less than 60 years old with verified stress urinary incontinence were included. All women were randomized to SIMS (Ajust
Introduction
Surgical treatment for urinary incontinence has changed considerably during recent decades. Originally, the Burch procedure was accepted as the gold standard surgical procedure but it includes an abdominal retropubic colposuspension, which is associated with a prolonged hospital stay and a high rate of anterior vaginal wall prolapse (1) . McGuire et al. (2) challenged the abdominal approach by introducing a retropubic autologue fascia sling in 1978. Ulf Ulmsten et al. (3) presented in 1996 a new ambulatory minimal invasive mid-urethral sling procedure under local anesthesia. This method is still referred to as the standard surgical procedure, with a cure rate up to 90%.
Since the introduction of the standard mid-urethral retropubic sling (SMUS) (3) this method has been modified by introduction of the transobturator approach. The main reason for the change was the higher rate of bladder perforation using the retropubic route (4) . However, several studies have shown that the transobturator procedure is associated with postoperative pain in the inner thigh (4) .
The single-incision mid-urethral sling (SIMS) was assumed to solve some of the complications associated with traditional slings, since it avoids the blind passage through the retropubic area and the groin and adductor muscles. This includes a shorter operation time, less blood loss and fewer complications and that it can be done under local anesthesia (5) . However, some studies report lower objective and patient-reported cure rates following the use of SIMS regardless of the type of SIMS used (6) or compared with retropubic slings (7) . Thus, the transvaginal tape (TVT)-Secur failed to improve outcome compared with TVT and was associated with severe complications such as hemorrhage (8) . Furthermore, Bernasconi et al. (9) demonstrated a TVT-Secur learning curve comparable to that of the TVT. One reason for varying results may be anchoring difficulties of previous SIMS (10) , whereas the Ajust â has been shown to be more stable attached to the obturator complex (11) . The technique of the adjustable SIMS Ajust â procedure (12) is close to that of the SMUS procedures (3) and, similar to these slings, the tension of the sling can be adjusted during the procedure. Most studies evaluating the efficacy of the Ajust â sling demonstrate a subjective cure rate of 80-86%, few complications (13) (14) (15) (16) (17) (18) (19) (20) and higher cost-effectiveness (20) . A recent multiple randomized trial in UK revealed that the mini-sling Ajust â was associated with lower postoperative pain perception and comparable subjective and objective cure rates compared with transvaginal tape-obturator (TVT-O) at short-term follow up (21) , in agreement with other studies (22) (23) (24) .
So far, no study has compared the Ajust â with other SMUS than the TVT-O. The primary aim of the present study was to compare the objective (negative stress test) and subjective (no leakage at all) cure rates of the adjustable single-incision mini-sling (SIMS) Ajust â vs. SMUS. The secondary aim was recording of pain perception and complications at the one-year follow up.
Material and methods
The trial was performed as a prospective multicenter randomized trial comparing Ajust â (C.R. Bard Inc., Murray
Hill, NJ, USA) with TVT (Ethicon Inc, Somerville, NJ, USA), TVT-O inside-out (Ethicon Inc) or transobturator tape (TOT) (Monarc AMS, MN, USA) as preferred by the eight local centers in Denmark, Norway and Sweden. This was to improve the generalizability of the outcome data.
The study was initiated in May 2012 and the study end point was April 2014. Prior to inclusion, all women were provided with verbal and written information with regard to the study protocol and gave their informed consent.
The participating surgeons screened the patients included. All surgeons were specialists in uro-gynecology; all had performed more than 100 SMUS procedures and a minimum of two Ajust procedures supervised by one of the main investigators prior to the inclusion of women in the randomized controlled trial. The use of local, spinal or general anesthesia depended on local regimens.
All women were randomized in blocks of 25 corresponding to each center by a computer-generated list in a ratio of 1:1 to either Ajust â or the SMUS used by the specific department. Randomization was done using sealed non-transparent envelopes. An independent statistician generated the random allocation sequence. All data were recorded following inclusion. All women included had a medical history of stress or mixed urinary incontinence defined as the complaint of involuntary leakage associated with urgency and stress incontinence. Stress incontinence had to be the
Key Message
So far, no comparison exists between the adjustable single-incision mini-sling (Ajust â ) and different types of standard mid-urethral slings (SMUS). This randomized controlled trial demonstrates that Ajust is as effective regarding objective and subjective cure rates and is associated with less pain perception following surgery.
dominating symptom defined as more episodes of leakage due to coughing or physical exertion than with urgency. All women included had stress urinary incontinence confirmed by a positive standardized cough test including 300 cm 3 in the bladder and had failed or declined pelvic floor muscle training.
Women were excluded if they were aged >60 years, had predominant urge incontinence, pelvic organ prolapse (Pelvic Organ Prolapse Quantification ≥stage 2), previous incontinence or pelvic organ prolapse surgery, planned or present pregnancy, residual urine volume >100 mL, previous pelvic irradiation, repeated urinary tract infections (four or more during the past year), neurological conditions such as multiple sclerosis, current treatment with corticoids, inability to understand the protocol, and a history of genital or abdominal cancer or a pelvic mass.
Preoperative assessment included women's medical history and physical examination, as well as questionnaires including pain diary. The same questionnaires were submitted 3 months after surgery. If the questionnaires were not resubmitted, the women received the forms once more, and if there was no response, the women was contacted by telephone and asked to fill out the questionnaires with the help of a study nurse. All women were invited to a one-year follow up, which included physical examination, a stress test (300 mL in the bladder), assessment of post-voiding residual volume and answering questionnaires.
The International Consultation on Incontinence Questionnaire (ICIQ-SF-UI), Patient Global Impression of Improvement (PGI-I) (25) and Patient Global Impression of Severity (PGI-S), and, if sexually active, the Pelvic Organ Prolapse/Urinary incontinence Sexual Questionnaire (PISQ-12) (26) were used to evaluate the influence of surgery on incontinence, quality of life and the women's perception of improvement. Only sexually active women were asked to answer PISQ-12. All women were asked to fill in bladder diaries for two consecutive days at inclusion and at follow ups.
All procedures were performed as described previously (6) . Briefly, the Ajust â utilizes a small sub-urethral incision similarly to mid-urethral slings. The mesh is anchored in the obturator membrane on both sides, and then adjusted similarly to the mid-urethral sling methods. Local anesthesia in combination with intravenous analgesics (Alfentanil 0.5 mg/mL; bolus injection) or general anesthesia was used in accordance with the preferences of each center. Cystoscopy was performed during the surgical procedure in all cases. Postoperatively, all analgesics used during a six-day period were recorded. All women were prescribed paracetamol 1 g every 6 h, and ibuprofen 200-400 mg up to 6-hourly if needed. Diclofenac sodium 50 mg could be used if further analgesia was needed.
Postoperative pain was recorded a fixed time daily using a 10-point visual analogue scale (VAS 0-10) during a sixday period (27) . A urinalysis and culture were evaluated if symptoms present including febrile morbidity or any lower urinary tract symptoms. The urine samples were collected in sterile bottles as clean-catch midstream urine. Bacteriuria was considered positive if the urine culture grew a single species of bacteria of at least 10 5 colony-forming units (cfu) per mL of urine.
The objective of the randomized controlled trial was to test the hypothesis that there was no difference between SMUS and SIMS regarding objective cure defined as a negative stress test, and subjective cure defined as zero incontinence episodes on the ICIQ-UI-SF. The secondary outcomes were pain perception (VAS score) and complications incurred at one-year follow up.
Statistical analyses
The study was conducted as a randomized trial. It was anticipated that the Ajust â group would be associated with an objective and subjective cure rate of not less than 9% compared with SMUS, which is in agreement with the difference observed between SMUS tests in the literature (differences between 85 and 94% cure rates) (28, 29) . The alpha value was set to 5% and a power of 80% to detect a significant difference of 9%. Using a one-sided test, this required the inclusion of 131 women in each arm (SIMS vs. SMUS). An anticipated dropout rate of 10% would increase the number of patients included to 144 women in each group. Data are presented as median interquartile range when not normally distributed (Shapiro-Wilcoxon test). Analysis was done by intention-to-treat regulations and imputation was done using multiple imputations on the main outcome for participants who were last at follow up. For nominal data we used Fisher's exact test and Chisquare test; for ordinal and non-normally distributed data we used Mann-Whitney U-test or Friedman's test for comparisons between groups. The Wilcoxon sign-rank test served as a post-hoc test to the Friedman's test. A reduced p-value (Bonferroni method) was used to control for the risk of mass significance. Relative risks were calculated to compare the efficacy of the two groups. Data were analyzed with SPSS version 21 (SPSS Inc., Chicago, IL, USA). 
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Results
In total, 305 women fulfilled the inclusion criteria (155 received Ajust â and 150 the SMUS: TVT, n = 83; TVT-O, n = 13; TOT, n = 54). Of these, 14 (9%) women did not participate in one-year follow up in the Ajust â group compared with 11 (7%) in the SMUS group ( Figure 1 ). Baseline characteristics are given in Table 1 . No difference was observed between the two groups. Baseline bladder function was equal in both groups ( Table 2) .
Duration of surgery is given in Table 3 . In one woman the Ajust â sling was not anchored sufficiently in the obturator membrane and she received an SMUS. Four women undergoing the SMUS procedure had lesions to the bladder (TVT, n = 3) or urethra (TVT, n = 1) and received an Ajust â sling. In one woman, Analyzed Analyzed the SMUS (TVT) was cut 2 weeks after surgery due to retention.
In total, 61% (Ajust â ) and 69% (SMUS) women received painkillers the first day after surgery (p = 0.239) and 13% vs. 16% at day 6 (p = 0.536). In all women except one, paracetamol or ibuprofen was the only analgesic taken.
We observed no difference between the groups regarding the number of days analgesics were taken. However, a significantly lower number of women experienced pain on day 6 following surgery in the Ajust â group (24%) than in the SMUS group (43%), p < 0.001 (Figure 2 ). At the 3-month follow up, one Ajust â and one sling in the SMUS group (TVT) had been cut due to retention and severe urgency, respectively. Other complications were minor and no difference was observed between the groups (Table 4) . One-year control demonstrated an equal objective cure rate in both groups (Table 5) , although lower compared with the subjective cure rate (ICIQ-UI-SF). The ICIQ score sum was reduced equally in both groups compared with inclusion values (Table 5) .
"Zero incontinence" episodes were more frequently recorded in bladder diaries than was "never incontinent" in ICIQ-UI-SF (83.3-88.9% vs. 50.7-60.0%; Table 5 ).
The percentage of women reporting "significantly improved" and "much improved" was 92.4% in the Ajust â group and 93.0% in the SMUS groups (p = 0.800). Similarly, the PGI-S declined simultaneously The hematoma was evacuated during the surgical procedure. in both groups without any difference between the groups at the one-year follow up ( One woman in the Ajust â group had recurrence of stress incontinence and received a TVT, and one woman in the TVT group became severely urge-incontinent, and received medication. One woman in the Ajust â group and two women in the SMUS (TVT) group experienced new mesh exposures at one-year follow up. All mesh exposures were resected and were not associated with recurrence of incontinence. In spite of having stated no wish for further pregnancies and being informed that pregnancy was not recommended, one woman became pregnant within a few months after surgery. She gave birth by a cesarean section within the study period without loss of continence at the one-year follow up.
The rate of dyspareunia was low and there was no difference between the groups (PISQ-12, Table 7 ).
Discussion
This study compared Ajust â with different types of SMUS, whereas most other studies compare Ajust â with because all types of SMUS are currently used. Furthermore, this would allow each center to use the sling with which they were most comfortable. Finally, a recent Cochrane review has demonstrated that the SMUS included were equally effective (3). Our primary aim was to evaluate subjective and objective cure rates in the two groups, and they appear to be equal. This is substantiated by the observation of no difference in the PGI-I, ICIQ-UI-SF scores and episodes of incontinence (bladder diary) between the groups. Thus, both groups showed an improvement above 90% (PGI-I), which is comparable to other studies (21) (22) (23) (24) . Our results are in agreement with most other reports evaluating the efficacy of Ajust â, indicating that Ajust â may represent an alternative to SMUS. However, the results must be interpreted bearing in mind that we only included women below 60 years. This age limit was selected to avoid an influence of age on the objective and subjective outcomes (30) . The influence of age remains to be evaluated when assessing the usefulness of Ajust â .
TVT-O (14-19). The design of the trial was chosen
One concern was the length of follow up. Several studies have demonstrated the durability of TVT (31) , although the cure rates have been shown to decrease with time. Thus, a one-year follow up is not sufficient to make any safe conclusion regarding the efficacy and safety of Ajust â . We are currently following women up to 36 months.
The objective outcome in all groups tended to be lower compared with subjective outcome (PGI-I) in contrast to previous observations (21, 22) . We have no explanation for this phenomenon, since the cough test was standardized and used by all centers in assessment of women with urinary incontinence.
Our study shows a discrepancy between subjective cure using ICIQ-SF and bladder diary, although both questionnaires report subjective outcomes. One explanation may be that the bladder diary is recorded over 1-2 days continuously during the registration period, whereas ICIQ-SF is an overall impression of the actual status of incontinence. Thus, the bladder diary may be more reliable. To our knowledge, the two questionnaires have not been compared in clinical trials. TVT-O group. The differences in postoperative pain between the groups in our study as well as previous studies are of clinical significance and may improve the postoperative outcome and an earlier return to work, as observed by others (16) . However, the difference in VAS score was not associated with a shorter hospital stay. One explanation may be lack of focus by the staff on the possibility of returning home earlier when possible and on other factors influencing the time of leaving the hospital. We observed a higher VAS score postoperatively in all groups compared with previous reports (21-23). Mostafa et al. (21) offered a similar analgesia protocol and observed a significantly lower pain perception especially in the Ajust â local anesthesia group, which could not be substantiated by our observations. Although the difference in VAS score was of more than 30%, and thus of clinical importance (27) , the explanation for the discrepancy between our and previous reported results is not clear. Although pain perception was less in the Ajust â group, we could not detect any difference in the number of painkillers taken or the number of days analgesics were taken during postoperative follow up. The explanation may be in general a low pain perception following Ajust â or that painkillers may be prescribed in general, thereby minimizing any difference between the groups. We did not observe any major complications in any of the groups. Vaginal perforation laterally was detected during the surgical procedure and was managed before the sling was placed. The defects were closed by suturing without complications. Similarly, only three mesh exposures were detected at the one-year follow up, comparable to previous reports (16) (17) (18) (19) .
Urinary tract infections were observed in 4.9% and 8.4% (Ajust â vs. SMUS) during the first 3 months of follow up but increased to 15.7% and 17.0%, respectively after one year. The increased number of infections cannot be attributed to increased residual volume. Previous studies have detected a much lower incidence of urinary tract infections of 3.5% (32) . One explanation may be that our trial is prospective, whereas other reports underestimate the incidence, being retrospective (30) . One woman became pregnant during the follow-up period but remained continent. Although the woman underwent cesarean section, a recent review (33) reported that the risk of postpartum stress urinary incontinence recurrence in women who underwent application of midurethral slings seems to be similar irrespective of the delivery mode (cesarean section or vaginal delivery). Similarly, more than 80% of women were continent at the one-year follow up (27) .
The strength of this study is the multicenter, prospective and randomized design. Furthermore, it is the largest study so far evaluating the efficacy of SIMS vs. SMUS in a randomized trial. The surgical procedures were standardized and all surgeons were skilled in sling procedures and underwent a course demonstrating the Ajust â procedure.
In conclusion, our study demonstrates that compared with SMUS, Ajust â appears to be associated with similar objective and subjective success rates and less pain perception following surgery.
